Roche Files Proxy, Sends Letter to Illumina Shareholders | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today said that it has filed a definitive proxy statement with the US Securities and Exchange Commission and sent a letter to Illumina's shareholders urging them to tender their shares in response to its $5.7 billion takeover bid.

It also urged Illumina's shareholders to vote in favor of Roche's nominees to Illumina's board.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: map of UV-induced damage in yeast genome, comparative epigenomics uncovers plant lacking key DNA methyltransferase enzyme, and more.

Researchers kick off their second Queer in STEM survey to examine what can make STEM careers welcoming, Wired reports.

A startup company is offering a test to analyze soil samples from farms for pathogens.

Prosecutors seek to introduce evidence from low-template DNA analysis in a murder case in upstate New York, the New York Times reports.